Back to results
US 2024/0229003 A1Published application
Cell-targeted cytotoxic constructs
AssigneeResearch Development Foundation
InventorsXinjian LIN, Xiying SHANG, Stephen B. HOWELL
Life of this patent
Estimating the term…
Abstract
The invention is directed to cell-targeted cytotoxic agents, including sortase serine protease constructs. Methods for targeted cell killing for treatment of proliferative diseases, for example, cancer, are provided. Exemplary embodiments comprise an R-spondin ligand for targeting the cytotoxic agents to effect the cell killing.
Claims19
-76. (canceled)
A cell-targeted cytotoxic construct comprising:
- (a) a targeting moiety that is an R-spondin targeting ligand that comprises two-tandem furin-like cysteine-rich (Fu-CRD) R-spondin domains, wherein the R-spondin targeting polypeptide ligand binds to a cell surface human LGR 4, LGR 5 and/or LGR 6 receptors;
- (b) a linking polypeptide that comprises a sortase recognition site, the linking polypeptide being positioned between the targeting moiety and the cytotoxic moiety;
- and
- (c) a cytotoxic moiety that comprises a toxin or chemotherapeutic, wherein the linking polypeptide is positioned between the targeting moiety and the cytotoxic moiety.
1 more element
Dependencies are inferred from the claim text.